Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Effects of Treatment With Biological Agents on Endothelial Glycocalyx,Arterial Elastic Properties, Coronary Flow, Myocardial Deformation and Twisting in Psoriasis. Comparative Study With Patients With CAD or Untreated Hypertension.
Sponsor: University of Athens
A PHASE4 clinical study on Psoriasis, this trial is ongoing. The trial is conducted by University of Athens and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Jun 2025 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Jun 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
May 2022 — Jun 2023 [monthly]
Recruiting PHASE4
▶ Show 6 earlier versions
-
Dec 2021 — May 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Recruiting PHASE4
-
May 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jan 2019 — May 2020 [monthly]
Recruiting PHASE4
Status: Unknown Status → Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Athens
For direct contact, visit the study record on ClinicalTrials.gov .